δEF1 upregulates CDK4 transcription via the E2-box element on the CDK4 promoter

Experimental and Therapeutic Medicine
Fen HuShuang Yang

Abstract

The zinc finger-homeodomain transcription factor, δ-crystallin enhancer factor 1 (δEF1) has been identified as a regulatory factor involved in the promotion of breast cancer cell proliferation via the downregulation of p21 and the upregulation of cyclin-dependent kinase-2 (CDK2) and CDK4 expression. However, the molecular mechanisms underlying the regulation of CDK4 expression by δEF1 have not yet been elucidated. The present study demonstrated that the ectopic expression of δEF1 in MDA-MB-231 breast cancer cells significantly increased the activity of the CDK4 promoter. Deletion of the E2-box (CACGTG), which is located at position -197/-191 on the human CDK4 promoter, significantly attenuated the activation of CDK4 transcription by δEF1. In addition, a CDK4 promoter-M construct was generated via site-directed mutagenesis of the E2-box on the human CDK4 promoter. Luciferase assay showed that the activation of CDK4 promoter-M activity by δEF1 was markedly decreased compared with the CDK4-promoter-0.4k promoter. Knockdown of δEF1 using RNA interference resulted in the inhibition of CDK4 promoter activity. These observations suggest that δEF1 upregulates CDK4 transcription via the E2-box element on the CDK4 promoter.

References

Oct 1, 1990·Trends in Biochemical Sciences·G Draetta
Nov 18, 1994·Cell·C J Sherr
Apr 17, 1998·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·R SekidoH Kondoh
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Nov 4, 2005·Journal of Cellular Biochemistry·C Elizabeth CaldonElizabeth A Musgrove
May 5, 2007·Journal of Biomedical Science·Shuang YangTianhui Zhu
Dec 17, 2009·Biochimica Et Biophysica Acta·Fen HuShuang Yang

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
Assay
transfection

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.